Role of chemotherapy in the management of soft tissue sarcomas.
about
LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potentialEGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potentialDog models of naturally occurring cancerThe evolution of systemic therapy in sarcoma.Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets.Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.Phase II studies in soft tissue sarcoma: time for reappraisal.Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survivalRetroperitoneal liposarcoma: current insights in diagnosis and treatmentManagement of patients with retroperitoneal tumors and a review of the literatureCross-sectional Imaging Features of Primary Retroperitoneal Tumors and Their Subsequent TreatmentClinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma casesRetroperitoneal Sarcoma. Outcome Analysis in a Teaching Hospital in Eastern India- a Perspective.Metabolomics strategy reveals subpopulation of liposarcomas sensitive to gemcitabine treatment.Improved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT.Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight PatientsSpermatic cord myxoid liposarcoma presenting as an incarcerated inguinal hernia: report of a case and review of literatures.Retroperitoneal tumours: review of management.Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study.Angiosarcoma of small bowel presenting with obstruction: novel observations on a rare diagnostic entity with unique clinical presentation.Retroperitoneal tumors in the pelvis: a diagnostic challenge in gynecology.Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature.Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies.Practical Issues for Retroperitoneal Sarcoma.Application of metabolomics in sarcoma: From biomarkers to therapeutic targets.Managing sarcoma: where have we come from and where are we going?Comparison between taxane-based chemotherapy with conventional surgery-based therapy for cutaneous angiosarcoma: a single-center experience.Clinical benefit of trabectedin in uterine adenosarcoma.Clinical benefit of early phase clinical trial participation for advanced sarcoma patients.Successful surgical treatment for huge retroperitoneal liposarcoma involving the pancreas, right kidney, abdominal aorta and inferior vena cava.Comparative oncology: Integrating human and veterinary medicine.Influence of Specialty and Clinical Experience on Treatment Sequencing in the Multimodal Management of Soft Tissue Extremity Sarcoma
P2860
Q26865711-DE1E38BB-EB5E-42D7-B771-0EFAC0E879F8Q28484249-93CBF1DD-7710-4494-94E8-580F43B656CEQ28742833-EC7288A3-9B99-4556-8D5E-80727EC0751BQ33274710-5443E946-7A60-4EB2-9941-700ACF968616Q33624398-3D8906F8-3407-4E82-A512-C341A8F85001Q33910609-54D7DC37-89EE-4314-93E9-28FD6A6FA34FQ34143849-64F40006-95D7-4691-BEB3-107EB1EF5B33Q35044274-97FE3B83-9143-46DB-83E9-4FF487A85780Q35066363-B29AF8C4-AC65-448B-848B-329293C80E52Q35504713-2D989123-0ABF-4650-B2C2-9A3C2CDE392FQ35575007-2A34F010-9CED-409E-92E6-E2171AB9667EQ35800303-D49DBA1E-D748-4BE0-8970-8429AFDE7B07Q36079901-17CC5A12-ABF5-4B17-A045-DA6BC61870D2Q36493132-EF545CFA-72AA-4D38-AC70-574D05E08F31Q37227499-F5CC38E5-9585-4133-8FF5-068A153E6464Q37624123-6E36C7E4-832E-45C8-9D43-ACC1FD5B2406Q37851053-D5EA6ACF-0D9D-4C55-9F9D-A2E4FB8F700AQ37938175-9B2C32E1-8310-4B97-9EBB-52287C50BF92Q38001658-34FB5B56-887C-4105-9B17-956A36A5D3EAQ38063861-97742908-4223-49E1-82D2-6CE8EBEAB3A3Q38320491-A391C13B-1D76-401E-914E-0AC60F24E3BFQ38581130-CF867593-F425-4591-89CB-665CC69725D1Q38683248-90CFE98C-008E-45B6-AA87-134B0B503745Q38936009-C2C2712F-357A-4953-AC6D-BA8158AA9031Q39426287-CF9F0F19-F845-4DB2-AEC1-0F1AFA714DFEQ41988197-18E8324C-7487-415D-81C8-A0271CF15CFAQ43619689-D4C3253D-5DF4-45D1-B068-8AD9F7D9CAF5Q43994749-DCDF87D8-EE6C-4059-BC90-A81D7F7CB1A3Q46177233-B1F3BFDB-FFFC-4A76-B830-D78A4D988A4BQ49240003-F16F1AF2-86F8-4DB3-945C-FDB3BC9FF26BQ49280135-BAE44A95-99B8-43B5-9D96-8D0CB9115A13Q57545132-26854DCC-516E-4BB4-BE08-6FF86FE301CC
P2860
Role of chemotherapy in the management of soft tissue sarcomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of chemotherapy in the management of soft tissue sarcomas.
@en
Role of chemotherapy in the management of soft tissue sarcomas.
@nl
type
label
Role of chemotherapy in the management of soft tissue sarcomas.
@en
Role of chemotherapy in the management of soft tissue sarcomas.
@nl
prefLabel
Role of chemotherapy in the management of soft tissue sarcomas.
@en
Role of chemotherapy in the management of soft tissue sarcomas.
@nl
P2860
P356
P1476
Role of chemotherapy in the management of soft tissue sarcomas.
@en
P2093
Dimitrios Krikelis
Ian Judson
P2860
P304
P356
10.1586/ERA.09.176
P577
2010-02-01T00:00:00Z